JP2016537652A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016537652A5 JP2016537652A5 JP2016552704A JP2016552704A JP2016537652A5 JP 2016537652 A5 JP2016537652 A5 JP 2016537652A5 JP 2016552704 A JP2016552704 A JP 2016552704A JP 2016552704 A JP2016552704 A JP 2016552704A JP 2016537652 A5 JP2016537652 A5 JP 2016537652A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarkers
- expression
- binding
- sample
- pancreatic cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1319878.3 | 2013-11-11 | ||
| GBGB1319878.3A GB201319878D0 (en) | 2013-11-11 | 2013-11-11 | Method, Array and use thereof |
| PCT/GB2014/053340 WO2015067969A2 (en) | 2013-11-11 | 2014-11-11 | Method, array and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016537652A JP2016537652A (ja) | 2016-12-01 |
| JP2016537652A5 true JP2016537652A5 (enExample) | 2017-12-07 |
| JP6600637B2 JP6600637B2 (ja) | 2019-10-30 |
Family
ID=49818441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552704A Expired - Fee Related JP6600637B2 (ja) | 2013-11-11 | 2014-11-11 | 膵臓がんを決定するための方法、アレイおよびそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20160252513A1 (enExample) |
| EP (1) | EP3069143B1 (enExample) |
| JP (1) | JP6600637B2 (enExample) |
| KR (1) | KR102240473B1 (enExample) |
| CN (1) | CN105917230B (enExample) |
| AU (1) | AU2014345484B2 (enExample) |
| BR (1) | BR112016010510A2 (enExample) |
| CA (1) | CA2930211A1 (enExample) |
| ES (1) | ES2704888T3 (enExample) |
| GB (1) | GB201319878D0 (enExample) |
| MX (1) | MX2016006125A (enExample) |
| WO (1) | WO2015067969A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3851856A3 (en) | 2007-03-27 | 2021-11-03 | Immunovia AB | Method, array and use thereof |
| GB201014837D0 (en) | 2010-09-07 | 2010-10-20 | Immunovia Ab | Biomarker signatures and uses thereof |
| GB201103726D0 (en) | 2011-03-04 | 2011-04-20 | Immunovia Ab | Method, array and use thereof |
| CN105021825B (zh) * | 2015-07-09 | 2016-08-17 | 陈勇 | 一种检测胰腺癌相关多肽dap44的elisa试剂盒 |
| GB201516801D0 (en) | 2015-09-22 | 2015-11-04 | Immunovia Ab | Method, array and use thereof |
| GB201608192D0 (en) * | 2016-05-10 | 2016-06-22 | Immunovia Ab | Method, array and use thereof |
| GB201609950D0 (en) * | 2016-06-07 | 2016-07-20 | Immunovia Ab | Biomarkers signatures and uses thereof |
| GB201609951D0 (en) * | 2016-06-07 | 2016-07-20 | Immunovia Ab | Biomarkers signatures and uses thereof |
| EP4053557A1 (en) * | 2016-11-24 | 2022-09-07 | Huvet Bio, Inc. | Il-29 as a marker for a pancreatic disease |
| GB201701572D0 (en) * | 2017-01-31 | 2017-03-15 | Immunovia Ab | Methods, arrays and uses thereof |
| KR102536314B1 (ko) * | 2018-05-23 | 2023-05-25 | 주식회사 휴벳바이오 | 질환의 진단용 조성물 |
| US11487739B2 (en) | 2019-02-19 | 2022-11-01 | Nasdaq, Inc. | System and methods for data model detection and surveillance |
| CA3138991A1 (en) * | 2019-05-02 | 2020-11-05 | Ligandal, Inc. | Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents |
| US20220326243A1 (en) * | 2019-05-21 | 2022-10-13 | Acurasysbio Co., Ltd. | Composition for cancer diagnosis |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| KR102226826B1 (ko) * | 2020-08-06 | 2021-03-11 | 주식회사 휴벳바이오 | 버피 코트 시료에 사용하기 위한 췌장암 진단용 조성물 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0039578B1 (en) | 1980-05-02 | 1985-04-10 | Edward P. Davis | Leg aid device |
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5856090A (en) | 1994-09-09 | 1999-01-05 | The Scripps Research Institute | DNA-methylase linking reaction |
| GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
| US6727066B2 (en) * | 2000-07-28 | 2004-04-27 | Incyte Corporation | Genes expressed in treated human C3A liver cell cultures |
| AU2003230838A1 (en) * | 2002-04-05 | 2003-10-27 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of | Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets |
| CN1703524B (zh) * | 2002-09-30 | 2010-04-07 | 肿瘤疗法科学股份有限公司 | 与人胰腺癌相关的基因和多肽 |
| US7250496B2 (en) * | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
| US7217807B2 (en) * | 2002-11-26 | 2007-05-15 | Rosetta Genomics Ltd | Bioinformatically detectable group of novel HIV regulatory genes and uses thereof |
| AU2004255216B2 (en) * | 2003-07-01 | 2010-08-19 | Immunomedics, Inc. | Multivalent carriers of bi-specific antibodies |
| CN102344493B (zh) * | 2004-05-28 | 2014-09-03 | 艾更斯司股份有限公司 | 结合于psca蛋白的用于癌症诊断的抗体 |
| US8383357B2 (en) * | 2005-03-16 | 2013-02-26 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
| EP1871911A2 (en) * | 2005-04-07 | 2008-01-02 | Chiron Corporation | Cancer-related genes (prlr) |
| JP2007051880A (ja) * | 2005-08-15 | 2007-03-01 | Tokyo Univ Of Science | 膵臓癌の検出方法、膵臓癌の診断キット |
| DK1974058T3 (da) * | 2006-01-11 | 2014-09-01 | Genomic Health Inc | Genekspressionsmarkører til prognosticering af kolorektal cancer |
| EP3851856A3 (en) * | 2007-03-27 | 2021-11-03 | Immunovia AB | Method, array and use thereof |
| SG182976A1 (en) * | 2007-06-29 | 2012-08-30 | Ahngook Pharmaceutical Co Ltd | Predictive markers for ovarian cancer |
| WO2009111067A2 (en) * | 2008-03-07 | 2009-09-11 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal -like tumor cells or their formation |
| GB0815846D0 (en) * | 2008-09-01 | 2008-10-08 | Immunovia Ab | diagnosis, prognosis and imaging of disease |
| CN113189342B (zh) * | 2009-03-12 | 2024-12-03 | 癌症预防和治疗有限公司 | 鉴定、评估、预防以及治疗肺疾病的方法及试剂盒 |
| WO2011039289A1 (de) * | 2009-09-29 | 2011-04-07 | Protagen Ag | Markersequenzen für pankreaskrebserkrankungen, pankreaskarzinom und deren verwendung |
| MY185582A (en) * | 2010-01-07 | 2021-05-24 | Malaysian Palm Oil Board | Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease |
| CN102279264A (zh) * | 2010-06-09 | 2011-12-14 | 李彬 | 48种恶性肿瘤标志物抗体芯片的制备方法 |
| US20120040858A1 (en) * | 2010-08-13 | 2012-02-16 | Morehouse School Of Medicine | Biomarkers for stroke |
| GB201103726D0 (en) * | 2011-03-04 | 2011-04-20 | Immunovia Ab | Method, array and use thereof |
| WO2012139628A1 (en) * | 2011-04-11 | 2012-10-18 | Lykera Biomed Sa | Coding polypurine hairpins for the treatment of cancer |
-
2013
- 2013-11-11 GB GBGB1319878.3A patent/GB201319878D0/en not_active Ceased
-
2014
- 2014-11-11 MX MX2016006125A patent/MX2016006125A/es unknown
- 2014-11-11 BR BR112016010510A patent/BR112016010510A2/pt not_active IP Right Cessation
- 2014-11-11 AU AU2014345484A patent/AU2014345484B2/en not_active Ceased
- 2014-11-11 US US15/035,953 patent/US20160252513A1/en not_active Abandoned
- 2014-11-11 CA CA2930211A patent/CA2930211A1/en not_active Abandoned
- 2014-11-11 CN CN201480071589.2A patent/CN105917230B/zh not_active Expired - Fee Related
- 2014-11-11 KR KR1020167015574A patent/KR102240473B1/ko not_active Expired - Fee Related
- 2014-11-11 EP EP14815406.5A patent/EP3069143B1/en not_active Not-in-force
- 2014-11-11 WO PCT/GB2014/053340 patent/WO2015067969A2/en not_active Ceased
- 2014-11-11 JP JP2016552704A patent/JP6600637B2/ja not_active Expired - Fee Related
- 2014-11-11 ES ES14815406T patent/ES2704888T3/es active Active
-
2018
- 2018-10-16 US US16/161,741 patent/US20190128891A1/en not_active Abandoned
-
2022
- 2022-03-25 US US17/704,057 patent/US20220214344A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016537652A5 (enExample) | ||
| Bader et al. | MS-based proteomics of body fluids: the end of the beginning | |
| Zhao et al. | Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application | |
| Kupcova Skalnikova et al. | Advances in proteomic techniques for cytokine analysis: focus on melanoma research | |
| Berezovski et al. | Aptamer-facilitated biomarker discovery (AptaBiD) | |
| Shi et al. | A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum | |
| US12205677B2 (en) | System and method for analysis of biological data | |
| US20200182874A1 (en) | Plasma autoantibody biomarkers for basal like breast cancer | |
| CN108034724B (zh) | 用于预测结直肠癌预后及死亡风险的环状rna分子标记物及其应用 | |
| JP2013541697A5 (enExample) | ||
| JP2010522875A5 (enExample) | ||
| CN107110867A (zh) | 用于肝癌诊断的生物标记物及其用途 | |
| Zhang et al. | Quantitative proteome‐based systematic identification of SIRT7 substrates | |
| Nie et al. | Deep-dive targeted quantification for ultrasensitive analysis of proteins in nondepleted human blood plasma/serum and tissues | |
| Schwenk et al. | Comparative protein profiling of serum and plasma using an antibody suspension bead array approach | |
| JP2016519767A5 (enExample) | ||
| CN104812914B (zh) | 诊断受试者中的肝癌的方法及诊断肝癌的试剂盒 | |
| Percy et al. | Multiplexed panel of precisely quantified salivary proteins for biomarker assessment | |
| JP2017508983A (ja) | サーマルシフトアッセイを使用して薬物反応の減少の指標となるバイオマーカーを識別するための方法 | |
| JP2016535270A5 (enExample) | ||
| KR20230074025A (ko) | 세포 노화 바이오 마커 ac008012.1, cldn11, hmgn2, chaf1b 또는 klhl13, 및 이를 이용한 세놀리틱 약물을 스크리닝 하는 방법 | |
| CN106011142A (zh) | 一种特异识别psa蛋白的寡核苷酸配基p7-26的序列和应用 | |
| US20230133776A1 (en) | Methods for diagnosing cancer | |
| Patel et al. | Extracellular Vesicle-Derived miRNAs as Diagnostic Biomarkers for Pancreatic Ductal Adenocarcinoma: A Systematic Review of Methodological Rigour and Clinical Applicability | |
| JP2017529074A (ja) | 治療剤に対する抵抗性の診断に使用するためのＥＲＣＣ１アイソフォーム３のｍＲＮＡおよび／またはタンパク質ならびにこのｍＲＮＡおよび／またはタンパク質を使用する治療剤に対する抵抗性を診断するための方法 |